Helicobacter pylori Infection Affects Immune Responses Following Vaccination of Typhoid-Naive US Adults With Attenuated Salmonella Typhi Oral Vaccine CVD 908-htrA

Serum pepsinogen II: A neglected but useful biomarker to differentiate between diseased and normal stomachs

(2011) Cai-yun He et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: A randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age

(2011) F. Matsuda et al.   VACCINE

Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine

(2010) Myron M Levine   BMC BIOLOGY

Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD− S. Typhi-specific IgA and IgG B memory cells in humans

(2010) Rezwanul Wahid et al.   CLINICAL IMMUNOLOGY

Performance of rotavirus vaccines in developed and developing countries

(2010) Victoria Jiang et al.   Human vaccines & immunotherapeutics

Immunology of gut mucosal vaccines

(2010) Marcela F. Pasetti et al.   IMMUNOLOGICAL REVIEWS

In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7×1010 colony-forming units

(2010) C.E. Lyon et al.   VACCINE

Typhoid Fever in the United States, 1999-2006

(2009) Michael F. Lynch et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION